Ikarian Capital, LLC
- SEC CIK
- 0001778253
- Latest filing
- Aug 14, 2026
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 85
- +3 vs. Q1 2024
- Portfolio value
- $320.5M
- −$47.2M (−12.8%) vs. Q1 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SRPTSarepta Therapeutics, Inc. | COM | 203,612 | $32.2M | 10.0% | +51,334+33.7% | Added | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 588,818 | $26.4M | 8.2% | −54,933−8.5% | Reduced | History |
| TARSTarsus Pharmaceuticals, Inc. | COM | 800,277 | $21.8M | 6.8% | +90,000+12.7% | Added | History |
| SLNOSoleno Therapeutics Inc | COM | 445,451 | $18.2M | 5.7% | −119,960−21.2% | Reduced | History |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 309,540 | $14.0M | 4.4% | −249,731−44.7% | Reduced | History |
| ELVNEnliven Therapeutics, Inc. | COM | 586,552 | $13.7M | 4.3% | +586,552 | New | History |
| AMGNAmgen Inc | Stock | 38,300 | $12.0M | 3.7% | +38,300 | New | History |
| NUVLNuvalent, Inc. | COM | 151,601 | $11.5M | 3.6% | +50,000+49.2% | Added | History |
| CYTKCytokinetics Inc | COM NEW | 170,147 | $9.22M | 2.9% | +25,000+17.2% | Added | History |
| NRIXNurix Therapeutics, Inc. | COM | 440,500 | $9.19M | 2.9% | +140,500+46.8% | Added | History |
| BBIOBridgeBio Pharma, Inc. | COM | 332,013 | $8.41M | 2.6% | +50,000+17.7% | Added | History |
| CPRXCatalyst Pharmaceuticals, Inc. | COM | 518,386 | $8.03M | 2.5% | 00.0% | Unchanged | History |
| VKTXViking Therapeutics, Inc. | COM | 138,262 | $7.33M | 2.3% | +138,262 | New | History |
| IMVTImmunovant, Inc. | COM | 276,925 | $7.31M | 2.3% | 00.0% | Unchanged | History |
| RNACCartesian Therapeutics, Inc. | COM NEW | 242,370 | $6.55M | 2.0% | +242,370 | New | History |
| SLRNACELYRIN, Inc. | COM | 1,475,074 | $6.51M | 2.0% | −89,266−5.7% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 40,000 | $5.51M | 1.7% | +40,000 | New | History |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 1,662,408 | $5.50M | 1.7% | 00.0% | Unchanged | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 489,642 | $4.55M | 1.4% | −100,000−17.0% | Reduced | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 197,096 | $4.24M | 1.3% | −100,000−33.7% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 107,187 | $4.18M | 1.3% | 00.0% | Unchanged | History |
| CRVOCervoMed Inc. | COM | 237,345 | $4.06M | 1.3% | 00.0% | Unchanged | History |
| RZLTRezolute, Inc. | COM NEW | 903,744 | $3.89M | 1.2% | +903,744 | New | History |
| Cybin Ord23256X100 | COM | 13,953,488 | $3.78M | 1.2% | 00.0% | Unchanged | – |
| LENZLENZ Therapeutics, Inc. | COM | 204,513 | $3.54M | 1.1% | +119,513+140.6% | Added | History |
| SLNSilence Therapeutics plc | ADS | 506,665 | $3.29M | 1.0% | +506,665 | New | History |
| INBXInhibrx Biosciences, Inc. | COM | 230,000 | $3.26M | 1.0% | +230,000 | New | History |
| ABEOAbeona Therapeutics Inc. | COM NEW | 768,593 | $3.26M | 1.0% | −120,000−13.5% | Reduced | History |
| INSMINSMED Inc | COM PAR $.01 | 47,835 | $3.20M | 1.0% | −3,500−6.8% | Reduced | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 458,497 | $3.12M | 1.0% | +370,000+418.1% | Added | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 201,116 | $2.91M | 0.9% | −174,194−46.4% | Reduced | History |
| WVEWave Life Sciences, Inc. | SHS | 575,088 | $2.87M | 0.9% | −15,000−2.5% | Reduced | History |
| JSPRJasper Therapeutics, Inc. | COM NEW | 105,175 | $2.39M | 0.7% | 00.0% | Unchanged | History |
| LRMRLarimar Therapeutics, Inc. | COM | 323,528 | $2.35M | 0.7% | −115,000−26.2% | Reduced | History |
| RCUSArcus Biosciences, Inc. | COM | 145,000 | $2.21M | 0.7% | +145,000 | New | History |
| QTTBQ32 Bio Inc. | COM | 109,094 | $1.96M | 0.6% | +86,759+388.4% | Added | History |
| ELEVElevation Acquisition Group Inc. | COM | 690,089 | $1.86M | 0.6% | +542,000+366.0% | Added | History |
| ANNXAnnexon, Inc. | COM | 380,000 | $1.86M | 0.6% | −1,025,000−73.0% | Reduced | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 302,908 | $1.83M | 0.6% | +302,908 | New | History |
| NKTRNektar Therapeutics | COM | 1,312,405 | $1.63M | 0.5% | +1,312,405 | New | History |
| SRRKScholar Rock Holding Corp | COM | 183,701 | $1.53M | 0.5% | −108,000−37.0% | Reduced | History |
| SGMTSagimet Biosciences Inc. | COM SER A | 412,565 | $1.41M | 0.4% | 00.0% | Unchanged | History |
| TRMLTourmaline Bio, Inc. | COM | 108,483 | $1.40M | 0.4% | 00.0% | Unchanged | History |
| IBIOiBio, Inc. | COM NEW | 600,000 | $1.27M | 0.4% | 00.0% | Unchanged | History |
| IFRXInflaRx N.V. | COM | 704,987 | $1.23M | 0.4% | 00.0% | Unchanged | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 1,443,181 | $1.18M | 0.4% | 00.0% | Unchanged | – |
| DFTXDefinium Therapeutics, Inc. | Stock | 162,481 | $1.17M | 0.4% | −135,000−45.4% | Reduced | History |
| ITOSiTeos Therapeutics, Inc. | COM | 78,574 | $1.17M | 0.4% | −22,751−22.5% | Reduced | History |
| KODKodiak Sciences Inc. | COM | 476,586 | $1.12M | 0.3% | 00.0% | Unchanged | History |
| ROIVRoivant Sciences Ltd. | SHS | 100,609 | $1.06M | 0.3% | 00.0% | Unchanged | History |
| NUVBNuvation Bio Inc. | COM CL A | 358,282 | $1.05M | 0.3% | −275,000−43.4% | Reduced | History |
| TECXTectonic Therapeutic, Inc. | COM | 62,836 | $1.03M | 0.3% | 00.0% | UnchangedConverted for a 1-for-12 split | History |
| VTYXVentyx Biosciences, Inc. | COM | 442,647 | $1.02M | 0.3% | −65,000−12.8% | Reduced | History |
| ALLKAllakos Inc. | COM | 972,675 | $972.7K | 0.3% | +40,000+4.3% | Added | History |
| MGNXMacrogenics Inc | COM | 200,079 | $850.3K | 0.3% | −118,088−37.1% | Reduced | History |
| DCTHDelcath Systems, Inc. | COM NEW | 100,370 | $840.1K | 0.3% | +100,370 | New | History |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 706,154 | $826.2K | 0.3% | +168,229+31.3% | Added | History |
| PRQRProQR Therapeutics N.V. | SHS EURO | 483,583 | $802.7K | 0.3% | 00.0% | Unchanged | History |
| VERUVeru Inc. | COM | 946,382 | $796.2K | 0.2% | 00.0% | Unchanged | History |
| LYELLyell Immunopharma, Inc. | COM | 526,066 | $762.8K | 0.2% | +526,066 | New | History |
| CLYMClimb Bio, Inc. | COM | 100,000 | $711.0K | 0.2% | +100,000 | New | History |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 54,730 | $682.5K | 0.2% | +8,082+17.3% | Added | History |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 266,435 | $644.8K | 0.2% | 00.0% | Unchanged | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 466,019 | $619.8K | 0.2% | 00.0% | Unchanged | History |
| JBIOJade Biosciences, Inc. | COM | 367,965 | $610.8K | 0.2% | 00.0% | Unchanged | History |
| IMTXImmatics N.V. | SHS | 49,415 | $574.2K | 0.2% | 00.0% | Unchanged | History |
| IMUXImmunic, Inc. | COM | 493,496 | $547.8K | 0.2% | −1,118,882−69.4% | Reduced | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 274,551 | $521.6K | 0.2% | −56,900−17.2% | Reduced | History |
| KZRKezar Life Sciences, Inc. | COM | 868,992 | $521.4K | 0.2% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 154,625 | $471.6K | 0.1% | 00.0% | Unchanged | History |
| VYGRVoyager Therapeutics, Inc. | COM | 55,857 | $441.8K | 0.1% | −125,000−69.1% | Reduced | History |
| ANEBAnebulo Pharmaceuticals, Inc. | COM | 157,862 | $431.0K | 0.1% | 00.0% | Unchanged | History |
| FTHFaeth Therapeutics, Inc. | COM | 650,000 | $403.1K | 0.1% | +650,000 | New | History |
| TARAProtara Therapeutics, Inc. | COM STK | 180,712 | $375.9K | 0.1% | −21,989−10.8% | Reduced | History |
| NYXHNyxoah SA | COMMONSTOCK | 50,699 | $356.9K | 0.1% | 00.0% | Unchanged | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 409,355 | $355.2K | 0.1% | 00.0% | Unchanged | History |
| LYRALyra Therapeutics, Inc. | COM | 1,056,829 | $292.4K | 0.1% | 00.0% | Unchanged | History |
| AEONAEON Biopharma, Inc. | CL A | 257,977 | $270.9K | 0.1% | 00.0% | Unchanged | History |
| TPSTTempest Therapeutics, Inc. | COM | 105,600 | $231.3K | 0.1% | 00.0% | Unchanged | History |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 213,392 | $196.3K | 0.1% | 00.0% | Unchanged | History |
| RLMDRelmada Therapeutics, Inc. | COM | 40,369 | $121.1K | <0.1% | 00.0% | Unchanged | History |
| STOKStoke Therapeutics, Inc. | COM | 6,816 | $92.1K | <0.1% | 00.0% | Unchanged | History |
| SYBXSynlogic, Inc. | COM NEW | 20,448 | $30.7K | <0.1% | 00.0% | Unchanged | History |
| BCLIBrainstorm Cell Therapeutics Inc. | COM NEW | 90,242 | $30.5K | <0.1% | 00.0% | Unchanged | History |
| CTMXCytomX Therapeutics, Inc. | COM | 8,924 | $10.9K | <0.1% | +8,924 | New | History |
Options (20)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| ALNYAlnylam Pharmaceuticals, Inc. | COM | $36.5M | $36.5M |
| INSMINSMED Inc | COM PAR $.01 | $4.75M | $34.0M |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | $17.5M | $12.4M |
| AMGNAmgen Inc | Stock | – | $18.7M |
| SRPTSarepta Therapeutics, Inc. | COM | – | $15.8M |
| BBIOBridgeBio Pharma, Inc. | COM | – | $15.2M |
| NBIXNeurocrine Biosciences Inc | Stock | – | $13.8M |
| AREAlexandria Real Estate Equities, Inc. | COM | $8.57M | – |
| AZNAstraZeneca PLC | SPONSORED ADR | – | $8.52M |
| CORTCorcept Therapeutics Inc | COM | – | $6.04M |
| GTHXG1 Therapeutics, Inc. | COM | $2.93M | $2.79M |
| VRDNViridian Therapeutics, Inc. | COM | $3.63M | $1.30M |
| SANASana Biotechnology, Inc. | COM | $2.18M | $2.18M |
| ANVSAnnovis Bio, Inc. | COM | $3.18M | $297.8K |
| IMVTImmunovant, Inc. | COM | – | $2.64M |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | $1.14M | $1.14M |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | – | $1.19M |
| RAPTRAPT Therapeutics, Inc. | COM | – | $610.0K |
| JBIOJade Biosciences, Inc. | COM | – | $166.0K |
| ABEOAbeona Therapeutics Inc. | COM NEW | – | $72.5K |
Sold out since Q1 2024 (13)
Positions held at the end of Q1 2024 that are gone from this filing.
| Security | Class | Shares in Q1 2024 | Value in Q1 2024 | % of portfolio in Q1 2024 | History |
|---|---|---|---|---|---|
| ALPNAlpine Immune Sciences, Inc. | COM | 261,365 | $10.4M | 2.8% | History |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 168,388 | $10.3M | 2.8% | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 51,541 | $7.70M | 2.1% | History |
| QUREuniQure N.V. | SHS | 469,133 | $2.44M | 0.7% | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 35,092 | $2.06M | 0.6% | History |
| ATXSAstria Therapeutics, Inc. | COM | 140,687 | $1.98M | 0.5% | History |
| IRONDisc Medicine, Inc. | COM | 25,372 | $1.58M | 0.4% | History |
| HOOKHOOKIPA Pharma Inc. | COM | 530,776 | $377.9K | 0.1% | History |
| EYPTEyePoint, Inc. | COM NEW | 1,047 | $21.6K | <0.1% | History |
| FNCHFinch Therapeutics Group, Inc. | COM NEW | 6,892 | $18.1K | <0.1% | History |
| TYRATyra Biosciences, Inc. | COM | 501 | $8.22K | <0.1% | History |
| Aslan Pharmaceuticals Ltd04522R200 | SPON ADS NEW | 35,420 | $6.27K | <0.1% | – |
| LBPHLongboard Pharmaceuticals, Inc. | COM | 236 | $5.10K | <0.1% | History |